Agenus Inc. announced that effective December 31, 2021, Dr. Jennifer Buell resigned as Agenus Inc.'s President and Chief Operating Officer to become the President and Chief Executive Officer of MiNK Therapeutics Inc., a subsidiary of the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.37 USD | +5.90% |
|
-8.41% | -14.48% |
06-17 | Agenus Appoints Jennifer Buell to Its Board of Directors | CI |
06-12 | Transcript : Agenus Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:00 AM |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.48% | 285M | |
+34.87% | 51.51B | |
-6.95% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+12.47% | 26.13B | |
-14.53% | 19.91B | |
+43.29% | 13.71B | |
+30.57% | 12.38B | |
-4.30% | 11.74B |
- Stock Market
- Equities
- AGEN Stock
- News Agenus Inc.
- Agenus Inc. Announces Resignation of Jennifer Buell as President and Chief Operating Officer